ライフサイエンスコーパス: ambulatory

1 contralateral neurological deficits but were ambulatory.

2 Ambulatory 24-h pH-impedance monitoring often reveals mo

3 Ambulatory 48-hour electrocardiograms from 7 astronauts

4 pathic, ranging from lethal neonatal to mild ambulatory adult patients.

5 prevent falls or fractures in this healthy, ambulatory, adult population.

6 Among ambulatory adults with hypertension, treating to a systo

7 ce and Medical Management) demonstrated that ambulatory advanced heart failure patients selected for

8 e noncardiac comorbidities were prevalent in ambulatory advanced HF patients, only depression was ass

9 New data have emerged from ambulatory and acute care settings about adverse patient

10 d baroreceptor reflex sensitivity (BRS) with ambulatory and beat-to-beat blood pressure (BP).

11 Numbers of ambulatory and ED diplopia presentations were estimated

12 Ambulatory and ED visits in the United States by patient

13 oking were independent risk factors for both ambulatory and hospitalized LRTI; delayed or incomplete

14 l on process-of-care and patient outcomes in ambulatory and inpatient settings.

15 asured in 28 adult patients, subdivided into ambulatory and non-ambulatory, suffering from a genetica

16 a large, multicenter cohort (ImagingDMD) of ambulatory and nonambulatory individuals with DMD; compa

17 arize the recent developments in the area of ambulatory and remote monitoring solutions for cardiac d

18 quires reliable, non-invasive, miniaturized, ambulatory, and inexpensive systems for continuous measu

19 A randomized controlled trial assigned ambulatory anorectal patients to ERAS (experimental) or

20 An ERAS protocol in ambulatory anorectal surgery is feasible, and resulted i

21 gen Klassifikation in 2 of 3, and North Star Ambulatory Assessment in all 5 tested.

22 001 [95% CI 31.14, 93.38 meters]; North Star Ambulatory Assessment, p < 0.001 [95% CI 2.702, 6.662 po

23 For 3 d before and after the intervention, ambulatory assessments were used to measure loneliness a

24 for noninferiority for the primary outcome (ambulatory at 8 weeks).

25 and 30-day readmission between inpatient and ambulatory-based surgery, respectively.

26 effective and can be safely administered on ambulatory basis.

27 Ambulatory beat-to-beat BP was recorded using a portable

28 e neural mechanisms underlying human natural ambulatory behavior is a major challenge for neuroscienc

29 -aminobutyric acid (GABA) influences daytime ambulatory blood pressure (BP) and other cardiometabolic

30 Ambulatory blood pressure (BP) variability also is assoc

31 ERI was measured using validated scales, and ambulatory blood pressure (BP) was measured every 15 min

32 stressed group (PHSG) with relatively higher ambulatory blood pressure and increased caloric intake.

33 mproving endothelial function but impacts on ambulatory blood pressure appear to be variable in indiv

34 ary end point was change in systolic daytime ambulatory blood pressure at 3 months.

35 ents demonstrated a significant reduction of ambulatory blood pressure compared with respective sham

36 At 3 months, systolic daytime ambulatory blood pressure decreased by 9.5+/-12.3 mm Hg

37 The prospective Sympathetic Activity and Ambulatory Blood Pressure in Africans (SABPA) study was

38 Blood pressure was assessed with 24-hour ambulatory blood pressure monitoring up to 3 years after

39 be monitored for hypertension (preferably by ambulatory blood pressure monitoring) and albuminuria.

40 Assessments included anthropometry, 24-h ambulatory blood pressure monitoring, and insulin sensit

41 stric bypass, considering office and 24-hour ambulatory blood pressure monitoring, respectively, wher

42 diogram (ECG), single-lead monitors (such as ambulatory blood pressure monitors and pulse oximeters),

43 outcome was placebo-corrected 24-h systolic ambulatory blood pressure reduction after 4 weeks and an

44 ody surface area, ejection fraction, 24-hour ambulatory blood pressure, hematocrit, and NT-proBNP (N-

45 ac energy status, cardiac ejection fraction, ambulatory blood pressure, plasma markers of inflammatio

46 ssess the efficacy and safety of ataluren in ambulatory boys with nonsense mutation DMD.

47 systematic differences between clinic BP and ambulatory BP (ABP) in a community sample of employed ad

48 ive validity of office blood pressure (OBP), ambulatory BP (ABP), and home BP (HBP) can inform which

49 points include diastolic AOBP, 24-hour mean ambulatory BP and safety.

50 lar in fat, has no overall effect on daytime ambulatory BP compared with a dairy-free diet.

51 Ambulatory BP data at 12 months were available from 4 tr

52 nt technique on BP readings, and explore how ambulatory BP data from the SPRINT trial may inform this

53 Patients with a daytime ambulatory BP greater >=135/85 mmHg and <170/105 mmHg af

54 nd 71/72 sham patients completed the 6-month ambulatory BP measurement.

55 250 participants completed a follow-up 24-h ambulatory BP monitoring (mean age: 70.4 +/- 6.4 y; 47.2

56 ained hypertension, and controlled BP), mean ambulatory BP monitoring and clinic BPs, and diurnal var

57 rticipants with CKD, BP metrics derived from ambulatory BP monitoring are associated with cardiovascu

58 These data support the wider use of ambulatory BP monitoring in the evaluation of hypertensi

59 Whether ambulatory BP monitoring is of value in evaluating risk

60 We evaluated, as exposures, ambulatory BP monitoring profiles (masked uncontrolled h

61 treated hypertension was defined as daytime ambulatory BP of at least 135/85 mm Hg and was further d

62 Intensive lowering of ambulatory BP reduction in older patients with hypertens

63 Ambulatory BP was measured for 24 hours to calculate mea

64 nsion treatment was adjusted on the basis of ambulatory BP), we simultaneously monitored BP and physi

65 endent of changes in mean clinic BP or awake ambulatory BP.

66 Patients undergoing ambulatory breast reconstruction can use follow-up care

67 pective cohort study of adult patients at an ambulatory cancer center with URI diagnoses from 1 Octob

68 troke, and presence or absence of post-index ambulatory cardiac monitoring.

69 Of all antibiotics, 54.1% were from ambulatory care (95% CI, 52.6%-55.7%), 38.0% were from t

70 h, 2019, 236 (30%) were randomly assigned to ambulatory care (n=117) and standard care (n=119).

71 of growth in spending in absolute terms were ambulatory care among all types of care and inpatient we

72 from mild to severe DR tracked from standard ambulatory care and investigated using Cox models.

73 gery, primarily due to higher utilization of ambulatory care and readmissions.

74 dividuals treated with immunosuppressants in ambulatory care are at increased risk of IPD caused by a

75 s, including 64 (55%) of 117 patients in the ambulatory care arm and 46 (39%) of 119 in the standard

76 there are an estimated 11 million visits to ambulatory care centers for pharyngitis in children betw

77 opia was defined by those who had at least 2 ambulatory care claims (International Classification of

78 lent myopia was defined as those who had >=2 ambulatory care claims (International Classification of

79 presented with acute respiratory illness at ambulatory care clinics in geographically diverse U.S. s

80 ss the burden of chronic symptomatic FBDs on ambulatory care delivery in the United States and evalua

81 ered by attending physicians in a variety of ambulatory care environments.

82 582) and $30965 ($629) and mainly accrued in ambulatory care for ART (70% of mean costs).

83 ergoing breast reconstruction at an academic ambulatory care hospital.

84 ization across the spectrum of inpatient and ambulatory care is useful to prioritize antibiotic stewa

85 The Flu VE Network enrolled ambulatory care patients aged >=6 months with acute resp

86 analysis is limited to available measures of ambulatory care quality and includes only 2 states.

87 produce valid, reliable, and stable ranks of ambulatory care quality for health care systems in Minne

88 Publicly reported measures of ambulatory care quality.

89 used the CANHEART (Cardiovascular Health in Ambulatory Care Research Team) cohort, created from link

90 g hospital readmissions, with many due to an ambulatory care sensitive condition.

91 readmission in the post-ICU period, 24% were ambulatory care sensitive condition.

92 ality, hospital readmissions (categorized by ambulatory care sensitive conditions and emergency depar

93 Only 11.5% of readmissions were for ambulatory care sensitive conditions compared with 23% o

94 a small proportion of readmissions were for ambulatory care sensitive conditions.

95 opic appendectomy in either the inpatient or ambulatory care setting.

96 Lack of testing for CM in ambulatory care settings within a region endemic for CM

97 do not encompass buprenorphine prescribed in ambulatory care settings, prisons, or jails.

98 view of influenza POCTs versus usual care in ambulatory care settings.

99 evaluate antibiotic use across inpatient and ambulatory care sites in an integrated healthcare system

100 ng data from the 2012-2015 National Hospital Ambulatory Care Survey.

101 in spending due to greater readmissions and ambulatory care visits.

102 rse events occurred in patients who received ambulatory care, eight (57%) of which were related to th

103 Ambulatory care, inpatient care, nursing care facility s

104 ality on pediatric hospitalization rates for ambulatory care-sensitive conditions (ACSCs) and whether

105 nt and associated 30-day postacute costs for ambulatory care-sensitive conditions (ACSCs).

106 dividuals treated with immunosuppressants in ambulatory care.

107 ta from community hospital and postdischarge ambulatory care.

108 Muscle tone and power as well as functional ambulatory category (FAC) were graded for the stroke pat

109 Index (LFI) scores for patients at multiple ambulatory centers.

110 prescription system for patients undergoing ambulatory cervical endocrine surgery (CES).

111 By empowering patients undergoing ambulatory CES to accept or decline a prescription, we r

112 The direct annual cost of ambulatory clinic visits alone for chronic symptomatic F

113 ng delays in diagnosis have been ascribed to ambulatory clinicians, but how their testing practices h

114 t dyads of hospital-based pediatric oncology ambulatory clinics and inpatient units between September

115 ults with physician-diagnosed psoriasis from ambulatory clinics were randomly assigned to either onli

116 ere made during hospital admission, 21.7% in ambulatory clinics, 3.2% in emergency units, and only 0.

117 irst case of consecutive patients undergoing ambulatory colectomy for malignant or benign disease.

118 al or infantile period and severe verbal and ambulatory comorbidities.

119 rospectively identified within inpatient and ambulatory databases at our institution.

120 ge, prospective, genotype-phenotype study of ambulatory DCM patients, we show that prognostic factors

121 hese findings in our validation cohort using ambulatory determination of O2 requirements.

122 y assigned (1:1) to treatment with either an ambulatory device or standard guideline-based management

123 thorax can be managed for outpatients, using ambulatory devices in those who require intervention.

124 ed >/=18 years with a hospital (inpatient or ambulatory) diagnosis of AD or psoriasis during the stud

125 roach with 27 variables from questionnaires, ambulatory diaries, and physical assessments collected e

126 Similar differential effects on office and ambulatory diastolic blood pressures, along with blood-p

127 ence (P = 0.34), which was also the case for ambulatory diastolic BP (P = 0.45).

128 , 95% CI: -3.06 to -0.35; p = 0.01), daytime ambulatory diastolic BP (WMD -1.57 mm Hg, 95% CI: -2.73

129 Hg, 95% CI: -8.18 to -2.87; p < 0.001), 24-h ambulatory diastolic BP (WMD -1.71 mm Hg, 95% CI: -3.06

130 sed as a symptomatic treatment to ameliorate ambulatory disability in multiple sclerosis.

131 der age of onset were more likely to develop ambulatory disability.

132 bulatory pediatric cardiology for a range of ambulatory domains.

133 ARIC study participants who wore a leadless, ambulatory ECG monitor (Zio XT Patch) for up to 2 weeks

134 tion with monitor-detected AF using a 14-day ambulatory ECG monitor was similar in the 4 race/ethnic

135 participated in an ancillary study involving ambulatory ECG monitoring and had follow-up for clinical

136 from 53,549 patients who used a single-lead ambulatory ECG monitoring device.

137 Long-term ambulatory ECG monitors provide the opportunity for unbi

138 cedures involving both a resting and 12-lead ambulatory ECG, an exercise stress test, and genetic scr

139 , of whom 77 had MS; 32 (42%) remained fully ambulatory (EDSS scores <=3.5), all of whom had relapsin

140 e cohorts (with the use of echocardiography, ambulatory electrocardiographic monitoring, exercise str

141 ticenter AIDS Cohort Study), using the ZioXT ambulatory electrocardiography patch.

142 At that time, ambulatory electroencephalography findings showed asymme

143 rpose of this study was to assess utility of ambulatory event monitoring (AEM) in identifying post-TA

144 nduit suturability and strength to withstand ambulatory forces over 4 weeks of their implantation.

145 ke survivors, and we examined its effects on ambulatory function, and long-term retention.

146 m EHR data from 2007-15 at Atrius Health, an ambulatory group practice in Massachusetts, USA.

147 a clinical diagnosis of achondroplasia, were ambulatory, had participated for 6 months in a baseline

148 As in clinical trials, use of ambulatory hemodynamic monitoring in clinical practice i

149 Ambulatory hemodynamic monitoring with an implantable pu

150 ncluding inpatient-to-clinic transitions and ambulatory HF systems-based care.

151 Consecutive ambulatory HFpEF patients admitted to a multidisciplinar

152 Ambulatory HIV-infected patients without active tubercul

153 al. investigated 3 rapid urine tests in 372 ambulatory HIV-negative individuals suspected of having

154 We determined BP thresholds for ambulatory hypertension in a US population-based sample

155 at any level in plasma from 684 asymptomatic ambulatory individuals.

156 Older patients remained ambulatory into their 60s.

157 nformation for Ventricular Assist Devices in Ambulatory Life) were analyzed using multivariable gener

158 poxemia, 4) a conditional recommendation for ambulatory liquid-oxygen use in patients who are mobile

159 order in fast-running mammals, while slower, ambulatory mammals more readily tolerate intermediate lu

160 he duration of hospitalisation and safety of ambulatory management compared with standard care.

161 Ambulatory management of primary spontaneous pneumothora

162 length of stay for colorectal surgery, until ambulatory management.

163 Ambulatory measurements of light and activity recorded w

164 Setting: National Hospital Ambulatory Medical Care Survey 2007-2015.

165 prespecified secondary analysis of National Ambulatory Medical Care Survey and National Hospital Amb

166 tient visit data from the 2005-2014 National Ambulatory Medical Care Survey and the National Hospital

167 ry Medical Care Survey and National Hospital Ambulatory Medical Care Survey data collected for a 10-y

168 Data from the National Ambulatory Medical Care Survey were used to estimate ann

169 edical Care Survey and the National Hospital Ambulatory Medical Care Survey.

170 Analysis of data from the National Hospital Ambulatory Medical Care Survey.

171 inology) billing, and data from the National Ambulatory Medical Care Survey.

172 for 13832 office visits (2010-2013 National Ambulatory Medical Care Surveys) and 108472 hospital sta

173 resentative data from the 1997-2016 National Ambulatory Medical Care Surveys, the authors examined tr

174 frequent gastrointestinal diagnoses made in ambulatory medicine clinics, and is a common source caus

175 evice was shown to operate effectively as an ambulatory monitor, allowing the reliable detection of a

176 sent during months 3 through 12; and 24-hour ambulatory monitoring conducted at 6 and 12 months.

177 Ambulatory monitoring devices are enabling a new paradig

178 Blood pressure was evaluated through ambulatory monitoring for 24 hours.

179 However, unbiased AF detection by ambulatory monitoring in the same individuals revealed l

180 Ambulatory monitoring is increasingly important for card

181 Ambulatory monitoring is required to assess PVC frequenc

182 Extended ambulatory monitoring was performed at 0 and 24 months.

183 runs of NSVT, including 17 before implant on ambulatory monitoring, 44 after ICD implantation, and 22

184 surement, the use of home blood pressure and ambulatory monitoring, and restricted use of beta-blocke

185 e clinic setting and elevated BP assessed by ambulatory monitoring, is associated with increased risk

186 majority of individuals undergoing long-term ambulatory monitoring.

187 ovascular events, the intermittent nature of ambulatory monitors and the variable clinical significan

188 ebrally intact volunteers were included: six ambulatory neurosurgical patients with parenchymal ICP-s

189 The change in mean ambulatory nighttime blood pressure from randomization s

190 but weak correlations among HRV, HR, BRS and ambulatory/office beat-to-beat BP.

191 suspicion for EFE, as patients are typically ambulatory on presentation without systemic signs of inf

192 t least 4 hours starting in the morning with ambulatory one-lead ECG monitors.

193 Projections showed that a 10% increase ambulatory operations would yield $3.6 million in annual

194 Data on efficacy of ambulatory options are poor.

195 ding attributable to admission, readmission, ambulatory or emergency care; monthly spending 6 months

196 At the ambulatory outpatient clinics of the Victorian Clinical

197 ypoxemia, 3) conditional recommendations for ambulatory oxygen use in patients with COPD (moderate-qu

198 heart failure (HF), affecting ~30% of stable ambulatory patients and 50% patients with acute decompen

199 Adult, nonpregnant, HIV-positive, ambulatory patients presenting for any HIV care, includi

200 Ambulatory patients receiving systemic cancer therapy ar

201 ed from February 1 to August 31, 2015, among ambulatory patients undergoing breast reconstruction at

202 etween noncardiac comorbidities and HRQOL in ambulatory patients with advanced HF.

203 -blind, randomized trial involving high-risk ambulatory patients with cancer (Khorana score of >=2, o

204 reported on DOACs for thromboprophylaxis in ambulatory patients with cancer at increased risk of VTE

205 .5 mg twice daily) for thromboprophylaxis in ambulatory patients with cancer who were at intermediate

206 did placebo among intermediate-to-high-risk ambulatory patients with cancer who were starting chemot

207 In high-risk ambulatory patients with cancer, treatment with rivaroxa

208 of discontinuation of digoxin on outcomes in ambulatory patients with chronic heart failure (HF) with

209 death declined substantially over time among ambulatory patients with heart failure with reduced ejec

210 lacebo-controlled randomized trial, eligible ambulatory patients with HF and reduced LVEF were recrui

211 In ambulatory patients with HF and reduced LVEF, thiamin su

212 ffered as the first-line treatment to stable ambulatory patients with OHS and coexistent severe obstr

213 strongly suspected of having OHS, 2) stable ambulatory patients with OHS receive positive airway pre

214 icoagulants with placebo or standard care in ambulatory patients with solid tumours and no indication

215 strong predictor of cardiovascular events in ambulatory patients with stable coronary heart disease a

216 WiFi-enabled iPod to obtain ECGs (iECGs) in ambulatory patients.

217 resulted in successful development of QMs in ambulatory pediatric cardiology for a range of ambulator

218 The ACPC sought to develop QMs for ambulatory pediatric cardiology practice.

219 ryptococcal antigen screening programmes for ambulatory people living with HIV who access care.

220 he tunnelled indwelling pleural catheter and ambulatory pleural drainage changed the management of ma

221 on of AF and assessment of AF duration in an ambulatory population when compared with an ICM.

222 prospective case series was conducted at the ambulatory practice of a hospitalist between January 1,

223 eadmissions (14% vs. 8%), and lower rates of ambulatory procedures (77% vs. 56%) for surgeons with th

224 The ambulatory rate for colectomy was 30.5%.

225 four drugs in the bloodstream of even awake, ambulatory rats, achieving precise molecular measurement

226 dynamics during cognitive tasks in a chronic ambulatory research setting.

227 ssion, pregnancy-specific distress, and 24-h ambulatory salivary cortisol) during the 2nd and 3rd tri

228 The insignificant change in ambulatory SBP (mean +/- standard deviation) was -0.6 +/

229 measure was the difference in change in 24 h ambulatory SBP between the groups.

230 mount of inorganic nitrate does not decrease ambulatory SBP in subjects with elevated BP.

231 DBP) of 90 mm Hg or greater, and a mean 24-h ambulatory SBP of 140 mm Hg or greater and less than 170

232 the results in the context of outcomes from ambulatory screening venues where 2%-10% of chronically

233 prosthesis on locomotion, we created a novel ambulatory searching task.

234 on wearable devices, smartphones, and other ambulatory sensors.

235 nificantly higher than those associated with ambulatory services.

236 additional 882 persons tested positive in an ambulatory setting before subsequent hospitalization, a

237 ts, and diagnoses were rarely serious in the ambulatory setting but potentially life threatening in 1

238 n-confirmed influenza virus infection in the ambulatory setting using a test-negative design.

239 objective measurement of RBD episodes in the ambulatory setting, and advances in imaging, biofluid, t

240 equent diagnoses was life threatening in the ambulatory setting, but approximately 16% of diplopia-re

241 acilitates cognitive testing in a controlled ambulatory setting, with measurements collected over mon

242 for elective colectomy can be managed in an ambulatory setting.

243 f index surgical cases were performed in the ambulatory setting.

244 onsumer Assessment of Health Plans Survey in ambulatory settings is incorporated as a complementary v

245 ngth evidence suggested that P4P programs in ambulatory settings may improve process-of-care outcomes

246 Among 69 studies, 58 were in ambulatory settings, 52 reported process-of-care outcome

247 characteristics of theta oscillations during ambulatory spatial navigation, while highlighting some f

248 The primary end point was ambulatory status at week 8, based on a 4-point scale an

249 Secondary end points included ambulatory status at weeks 1, 4, and 12 and overall surv

250 sex, race, insurance coverage, arrival mode, ambulatory status before the current stroke, stroke seve

251 Ambulatory status grade 1 or 2 at week 8 was achieved by

252 The difference in ambulatory status grade 1 or 2 in the single-fraction vs

253 noninferiority margin for the difference in ambulatory status was -11%.

254 Age, SMA type, and ambulatory status were significantly associated with cha

255 CU stay, presence of an ostomy, patient age, ambulatory status, and presence of a fecal management sy

256 mbolysis in Cerebral Infarction score 2b-3), ambulatory status, global disability (modified Rankin Sc

257 erized samples, especially those integrating ambulatory stress assessments, will be well positioned t

258 n about potential rural/urban differences in ambulatory stroke care.

259 hisms associated with atrial fibrillation in ambulatory studies using a Sequenom platform (San Diego,

260 patients, subdivided into ambulatory and non-ambulatory, suffering from a genetically confirmed 5q-SM

261 nt department versus physician office versus ambulatory surgery center).

262 < 0.001; physician office: 22.1%, P < 0.001; ambulatory surgery center: 36.6%, P < 0.001).

263 for procedure type, procedures performed in ambulatory surgery centers conferred an additional $2019

264 Among 83 021 procedures performed at ambulatory surgery centers with in-network primary surge

265 Ambulatory surgery offers significant costs savings and

266 observational cohort study at inpatient and ambulatory surgery settings in New York State.

267 se documenting hospital, emergency room, and ambulatory surgery visits and investigated the incidence

268 colectomy and meeting rigorous criteria for ambulatory surgery were included.

269 in a hospital/facility-based and nonfacility/ambulatory surgical center (ASC)-based setting.

270 would reduce expenditures, efforts to expand ambulatory surgical practices may result in the largest

271 (SSIs) on health care costs following common ambulatory surgical procedures throughout the cost distr

272 Therefore, the development of ambulatory systems providing continuous, comfortable, an

273 is crucial for the development of ECG-based ambulatory systems.

274 p, there was significant lowering of overall ambulatory systolic blood pressure (adjusted difference

275 The reduction in 24-h ambulatory systolic blood pressure (ASBP) was significan

276 ated a 6.3 mmHg greater reduction in daytime ambulatory systolic blood pressure (BP) at 2 months by e

277 mary end point was the change in the 24-hour ambulatory systolic blood pressure between baseline and

278 odipine plus perindopril had a lower 24-hour ambulatory systolic blood pressure than those receiving

279 s included the 6-month (i) change in daytime ambulatory systolic BP adjusted for medications and base

280 Comparison of postdiet ambulatory systolic BP revealed no difference (P = 0.34)

281 te less intensive SSAHT, RDN reduced daytime ambulatory systolic BP to a greater extent than sham (-1

282 14 patients with available data who received ambulatory treatment (0 days [IQR 0-3]) than in the 113

283 ars with genetically confirmed type 2 or non-ambulatory type 3 SMA.

284 Ambulatory urodynamic monitoring (AUM) uses physiologica

285 d validation in academic and community-based ambulatory urology clinics.

286 s and grade 5 of 5 muscle power) or grade 2 (ambulatory using aids or grade 4 of 5 muscle power).

287 urgical costs were significantly lower among ambulatory versus inpatient cases for all 4 procedures (

288 CI, 0.32-0.43; P < 0.001) were lower in the ambulatory versus inpatient setting.

289 Readmission rates among ambulatory versus inpatient-based laparoscopic appendect

290 The CAVA (Continuous Ambulatory Vestibular Assessment) device has been develo

291 tension with a high BP measurement during an ambulatory visit received an order for a new antihyperte

292 stimate annual rates and associated costs of ambulatory visits for symptomatic irritable bowel syndro

293 ed upper respiratory infections) recorded in ambulatory visits from 2007 to 2016.

294 ive FBD management because fewer than 1 in 5 ambulatory visits include nonpharmacologic treatment str

295 Most diplopia-related ambulatory visits were conducted by ophthalmologists (70

296 Yearly, there were more than 54.4 million ambulatory visits with a primary diagnosis for a GI dise

297 with hypertension who completed ~3.1 million ambulatory visits.

298 n (SD) patient age was 62.1 (20.3) years for ambulatory vs 48.1 (22.3) years for diplopia-related ED

299 n a 4-point scale and classified as grade 1 (ambulatory without the use of aids and grade 5 of 5 musc

300 Ambulatory wrist blue light irradiance and skin temperat